Red Maple - 49288-0322-4 - (Red Maple)

Alphabetical Index


Drug Information of Red Maple

Product NDC: 49288-0322
Proprietary Name: Red Maple
Non Proprietary Name: Red Maple
Active Ingredient(s): .05    g/mL & nbsp;   Red Maple
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Red Maple

Product NDC: 49288-0322
Labeler Name: Antigen Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 19740323

Package Information of Red Maple

Package NDC: 49288-0322-4
Package Description: 30 mL in 1 VIAL, MULTI-DOSE (49288-0322-4)

NDC Information of Red Maple

NDC Code 49288-0322-4
Proprietary Name Red Maple
Package Description 30 mL in 1 VIAL, MULTI-DOSE (49288-0322-4)
Product NDC 49288-0322
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Red Maple
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19740323
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name ACER RUBRUM POLLEN
Strength Number .05
Strength Unit g/mL
Pharmaceutical Classes Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Red Maple


General Information